» Articles » PMID: 30902577

NLRP12 Regulates Anti-viral RIG-I Activation Via Interaction with TRIM25

Abstract

Establishing the balance between positive and negative innate immune mechanisms is crucial for maintaining homeostasis. Here we uncover the regulatory crosstalk between two previously unlinked innate immune receptor families: RIG-I, an anti-viral cytosolic receptor activated type I interferon production, and NLR (nucleotide-binding domain, leucine repeat domain-containing protein). We show that NLRP12 dampens RIG-I-mediated immune signaling against RNA viruses by controlling RIG-I's association with its adaptor MAVS. The nucleotide-binding domain of NLRP12 interacts with the ubiquitin ligase TRIM25 to prevent TRIM25-mediated, Lys63-linked ubiquitination and activation of RIG-I. NLRP12 also enhances RNF125-mediated, Lys48-linked degradative ubiquitination of RIG-I. Vesicular stomatitis virus (VSV) infection downregulates NLRP12 expression to allow RIG-I activation. Myeloid-cell-specific Nlrp12-deficient mice display a heightened interferon and TNF response and are more resistant to VSV infection. These results indicate that NLRP12 functions as a checkpoint for anti-viral RIG-I activation.

Citing Articles

Innate Immunity Never "NODs" Off: NLRs Regulate the Host Anti-Viral Immune Response.

Woolls M, Mott M, Poole C, Gregory J, Ivester H, Allen I Immunol Rev. 2025; 330(1):e13429.

PMID: 39878363 PMC: 11776368. DOI: 10.1111/imr.13429.


The role of pyroptosis in cancer: key components and therapeutic potential.

Liu Z, Xu S, Chen L, Gong J, Wang M Cell Commun Signal. 2024; 22(1):548.

PMID: 39548573 PMC: 11566483. DOI: 10.1186/s12964-024-01932-z.


The E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation.

Cheng M, Lu Y, Wang J, Wang H, Sun Y, Zhao W Cell Death Differ. 2024; 31(12):1746-1760.

PMID: 39266719 PMC: 11618372. DOI: 10.1038/s41418-024-01376-5.


Overexpression of NLRP12 enhances macrophage immune response and alleviates herpes simplex keratitis.

Jiang J, Zhang D, Liu W, Yang J, Yang F, Liu J Front Cell Infect Microbiol. 2024; 14:1416105.

PMID: 39119293 PMC: 11306119. DOI: 10.3389/fcimb.2024.1416105.


TRIM26 facilitates PRV infection through NDP52-mediated autophagic degradation of MAVS.

Chengyue W, Mengdong W, Xiaoquan W, Yeping C, Hao L, Liumei S Vet Res. 2024; 55(1):84.

PMID: 38965634 PMC: 11225307. DOI: 10.1186/s13567-024-01336-4.


References
1.
Gack M, Shin Y, Joo C, Urano T, Liang C, Sun L . TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 2007; 446(7138):916-920. DOI: 10.1038/nature05732. View

2.
Kim J, Park M, Nikapitiya C, Kim T, Uddin M, Lee H . FAS-associated factor-1 positively regulates type I interferon response to RNA virus infection by targeting NLRX1. PLoS Pathog. 2017; 13(5):e1006398. PMC: 5456407. DOI: 10.1371/journal.ppat.1006398. View

3.
Wang L, Manji G, Grenier J, Al-Garawi A, Merriam S, Lora J . PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem. 2002; 277(33):29874-80. DOI: 10.1074/jbc.M203915200. View

4.
Seth R, Sun L, Ea C, Chen Z . Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005; 122(5):669-82. DOI: 10.1016/j.cell.2005.08.012. View

5.
Cui J, Li Y, Zhu L, Liu D, Songyang Z, Wang H . NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol. 2012; 13(4):387-95. PMC: 3760161. DOI: 10.1038/ni.2239. View